CWA Asset Management »

Theravance Biopharma shares owned by CWA Asset Management

Quarter-by-quarter ownership of Theravance Biopharma (TBPH) shares owned by CWA Asset Management from 13F filings

Historical chart of CWA Asset Management investment in Theravance Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Theravance Biopharma held by CWA Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Theravance Biopharma by CWA Asset Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $1.5M 95k 16.23

More positions owned by CWA Asset Management

NVIDIA Corporation Put Option (NVDA)
Apple Put Option (AAPL)
Microsoft Corporation (MSFT)
Ishares Tr 1 3 Yr Treas Bd (SHY)
Spdr Gold Tr Gold Shs (GLD)
Amazon (AMZN)
Alphabet Cap Stk Cl C (GOOG)
Capitol Ser Tr Sterling Cap Enh (SCEC)
Alphabet Cap Stk Cl A Call Option (GOOGL)
Texas Pacific Land Corp (TPL)
Vanguard Scottsdale Fds Int-term Corp (VCIT)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Orla Mining LTD New F (ORLA)
Spdr Series Trust State Street Spd (BIL)
Noble Corp Ord Shs A (NE)

View all positions for CWA Asset Management

Top funds holding Theravance Biopharma

Madison Avenue Partners
Weiss Asset Management LP[1
Newtyn Management
BlackRock
Irenic Capital Management
Vanguard Group
D. E. Shaw & Co
Acadian Asset Management
State Street Corporation
Arrowstreet Capital, Limited Partnership
Geode Capital Management
Dimensional Fund Advisors
Oasis Management
UBS Group
Two Sigma Investments

View all funds holding Theravance Biopharma